DS-1205c With Gefitinib for Metastatic or Unresectable Epidermal Growth Factor Receptor (EGFR)-Mutant Non-Small Cell Lung Cancer
Clinical trial NCT03599518 · TERMINATED
Trial details
- NCT number
- NCT03599518
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-09-21
- Primary completion
- 2020-04-22
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.